Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $319.37
    +1.40 (+0.44%)

    Market Cap: $113.81B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    CME Group Inc (CME) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect CME Group (CME) to earn $12.40 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.09B. Of 17 analysts, 9 rate the stock Buy or Strong Buy, 6 Hold and 2 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 13 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.35, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 53% of the ratings.

    RatingAnalystsShare
    Strong Buy529.4%
    Buy423.5%
    Hold635.3%
    Sell15.9%
    Strong Sell15.9%
    Consensus
    Buy
    Total analysts
    17

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 6.9% and revenue estimates rise 5.4%.

    Fiscal year ending Dec 31, 2026
    $12.40
    EPS consensus, revenue $7.09B
    Fiscal year ending Dec 31, 2027
    $13.25
    EPS consensus, revenue $7.47B
    Next report
    Feb 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$12.40$12.29 to $12.6617$7.09B$7.04B to $7.13B14
    Dec 31, 2027$13.25$12.38 to $13.7017$7.47B$7.11B to $7.74B14

    Quarterly Estimates

    The EPS consensus rises from $3.06 for the quarter ending Dec 31, 2026 to $3.32 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$3.06$2.86 to $3.4416$1.79B$1.69B to $1.97B15
    Mar 31, 2027$3.32$3.05 to $3.6012$1.86B$1.73B to $1.97B8

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 33 upward and 6 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026131
    Fiscal year ending Dec 31, 2027131
    Quarter ending Mar 31, 202774

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.1% from $12.27.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$12.40$12.40$12.30$12.25$12.27+1.1%
    Fiscal year ending Dec 31, 2027$13.25$13.23$12.99$12.93$12.93+2.4%
    Quarter ending Mar 31, 2027$3.32$3.30$3.28$3.29$3.29+1.1%

    Frequently Asked Questions About CME

    What is the CME stock forecast?

    Consensus analyst estimates put CME Group's EPS at $12.40 for the fiscal year ending Dec 31, 2026, on revenue of $7.09B. The consensus rating from 17 analysts is Buy.

    How do analysts rate CME stock?

    Of 17 analysts covering CME Group, 5 rate it Strong Buy, 4 Buy, 6 Hold, 1 Sell and 1 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from CME next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $12.40, with estimates from $12.29 to $12.66 from 17 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $13.25, with estimates from $12.38 to $13.70 from 17 analysts.

    What revenue do analysts expect from CME Group next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.09B, with estimates from $7.04B to $7.13B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $7.47B, with estimates from $7.11B to $7.74B.

    How many analysts cover CME?

    17 analysts rate CME Group stock, and 17 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.